Health

FDA Approves Andembry (garadacimab-gxii) for Prophylaxis to Prevent Attacks of Hereditary Angioedema

DailyTrendDailyTrend
Jun 17, 2025 - 19:00
 0  0
FDA Approves Andembry (garadacimab-gxii) for Prophylaxis to Prevent Attacks of Hereditary Angioedema
KING OF PRUSSIA, Pa., June 16, 2025 /PRNewswire/ -- Global biotechnology leader CSL today announced the U.S. Food and Drug Administration (FDA) approved Andembry (garadacimab-gxii), the only treatment targeting factor XIIa for prophylactic use to...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Psych 101: What Is Tapping?

DailyTrend Jun 20, 2025  0  0

Infusion Pump Recall: Zyno Medical Removes Certain Z-800 Series Infusion Pumps due to Software Issue

Infusion Pump Recall: Zyno Medical Removes Certain Z-80...

DailyTrend Jun 17, 2025  0  0

FDA Approves Yeztugo (lenacapavir) as the First and Only HIV Prevention Option Offering 6 Months of Protection

FDA Approves Yeztugo (lenacapavir) as the First and Onl...

DailyTrend Jun 19, 2025  0  0

Trump’s Cuts to N.I.H. Grants Focused on Minority Groups Are Illegal, Judge Rules

Trump’s Cuts to N.I.H. Grants Focused on Minority Group...

DailyTrend Jun 17, 2025  0  0

When Humans Learned to Live Everywhere

DailyTrend Jun 18, 2025  0  0

People With Severe Diabetes Are Cured in Small Trial of New Drug

People With Severe Diabetes Are Cured in Small Trial of...

DailyTrend Jun 20, 2025  0  0